Physician profile
Jill Edwards
NPI 1356462006
$603.00
in general payments reported to CMS, 2019-2025
12 companies · $344 in 2025
The $344 reported for 2025 was more than what 91% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $69.22 · 2022: $16.94 · 2023: $36.78 · 2024: $136 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $186.43 | 2025 | |
| Exeltis, USA INC. | $101.41 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $83.77 | 2024-2025 | |
| Becton, Dickinson and Company | $45.40 | 2023-2025 | Bd Veritor Plus Analyzer, Bd Onclarity |
| Pfizer INC. | $41.06 | 2023-2024 | |
| Abbvie INC. | $41.04 | 2021 | |
| Hologic Sales and Service, LLC | $26.67 | 2024 | Aptima |
| Organon LLC | $17.08 | 2024 | |
| Coloplast Corp | $16.09 | 2024 | |
| Coopersurgical, INC. | $15.87 | 2025 | Paragard T 380a |
| Amgen INC. | $14.77 | 2021 | |
| Boston Scientific Corporation | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.